Nurse 5 popular Gifts Nutritional Facts Gift Nursing Gag Label Nursing,Gifts,Nurse,Home Kitchen , Kitchen Dining , Dining Entertaining,Gift,loft-ministerstvo.ru,Label,Gift,/motophone548777.html,Facts,$10,Gag,Nutritional,Nurse Nurse 5 popular Gifts Nutritional Facts Gift Nursing Gag Label $10 Nurse Gifts Nurse Nutritional Facts Label Nursing Gag Gift Gift Home Kitchen Kitchen Dining Dining Entertaining $10 Nurse Gifts Nurse Nutritional Facts Label Nursing Gag Gift Gift Home Kitchen Kitchen Dining Dining Entertaining Nursing,Gifts,Nurse,Home Kitchen , Kitchen Dining , Dining Entertaining,Gift,loft-ministerstvo.ru,Label,Gift,/motophone548777.html,Facts,$10,Gag,Nutritional,Nurse

Nurse Max 71% OFF 5 popular Gifts Nutritional Facts Gift Nursing Gag Label

Nurse Gifts Nurse Nutritional Facts Label Nursing Gag Gift Gift

$10

Nurse Gifts Nurse Nutritional Facts Label Nursing Gag Gift Gift

|||

Product Description

Check out these other great gifts for nurses!

No matter what nursing field they practice, we have a gift that is sure to put a smile on their face.

"tbody" "th" Nurse Gifts Nurse Nutritional Facts Label Nursing Gag Gift Gift Coffee Mug "th" Nurse Spelled with Periodic Table Elements Ladies T-Shirt "th" Engraved Crystal Adorned Heart Pendant Lobster Claw Bracelet Gift for Nurse "th" I am a Nurse Poem Natural Wood Engraved 4x6 Portrait Picture Frame Wood "th" I'm a Grandma and a Nurse Nothing Scares Me RN Nurse Gift Coffee Mug
Mug Shirt Bracelet Frame Mug Shirt
Nursing Student Gifts I Can't I'm in Nursing School Ladies T-Shirt

Nurse Gifts Nurse Nutritional Facts Label Nursing Gag Gift Gift

CURRENT ISSUE
September, 2021

No. 106 (9)

2020 Impact Factor: 9.941 Submission > Acceptance: 52 days
ARTICLES IN THREE SENTENCES
Article

Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

This open-label, single-arm study investigated the long-term efficacy of tafasitamab plus lenalidomide in 81 patients with relapsed/refractory diffuse large B-cell lymphoma. The response rate was 57.5%, including complete responses in 40.0% of patients, and the median duration of response was 43.9 months. This treatment is a valuable option for patients not eligible for autologous stem-cell transplantation.

Johannes Duell et al.

Case Report

Clinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients

Grey zone lymphoma is a B-cell lymphoma, unclassifiable, with features intermediate between those of large B-cell lymphoma and classic Hodgkin lymphoma. The in-depth study of the two adolescent patients described in this case report expands the clinicopathological and genomic spectrum of this rare pediatric disease. Moreover, it provides information on their response to treatment.

Cagla Y. Benkli et al.

Article

CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients

The clinical picture of 56 patients with congenital amegakaryocytic thrombocytopenia due to MPL mutations was much more varied than previously thought. Twenty-five per cent of them had no signs of thrombocytopenia at birth, and 50% had non-hematologic defects. Pancytopenia developed in (nearly) all patients and hematopoietic stem-cell transplantation was effective in 87% of cases.

Manuela Germeshausen et al.

Article

Oxidative stress activates red cell adhesion to laminin in sickle cell disease

Sickle red blood cells exhibit abnormal adhesion to laminin mediated by Lu/BCAM protein at their surface. This study provides evidence of the involvement of oxidative stress in post-translational modifications of Lu/BCAM which impact the protein’s distribution and cis-interaction with glycophorin C at the cell surface activating its adhesive function in dense sickle red cells. The authors speculate that antioxidant drugs might attenuate this phenomenon.

Maria Alejandra Lizarralde-Iragorri et al.

TAKE ADVANTAGE FROM HAEMATOLOGICA